This study compared three different thrombin generation assays in patients with hemophilia A. The assays were an in-house test, Thrombogram, and Ceveron Alpha. 46 male patients with hemophilia A and 25 healthy volunteers were tested. The results showed that all assays could distinguish patients from controls, but their sensitivities differed. The in-house assay had the highest sensitivity for peak height compared to the other tests. While harmonizing the results improved correlations between assays, differences still remained likely due to variations in tissue factor and phospholipid concentrations between tests.
Quantification of a Novel Peptide, CPT31 in Rat and Monkey Plasma by LC-MSCovance
ASMS 2019 -- CPT31, a novel D-peptide, is being investigated in the treatment and prevention of HIV by inhibiting the viral entry of HIV. To evaluate the properties of CPT31, an accurate highly reproducible method to quantitate CPT31 in plasma was required. To this end, a robust LC-MS assay for the quantification of CPT31 in rat and monkey plasma samples is reported here. The method follows extraction and clean-up of two plasma matrices, encompasses a range of 90.0 to 45,000 ng/mL, and completes LC-MS analysis in 7.50 minutes.
VALIDATED LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY METHOD FOR DETERMINA...Manik Ghosh
A simple, highly sensitive and rapid LC-MS/MS method has been developed and validated for the quantification of metolazone in rat plasma using irbesartan as internal standard (IS). After simple protein precipitation extraction by acetonitrile, the analyte and IS were extracted from 50 μL plasma sample on an Agilent Poroshell 120, EC- C18 (50 mm × 4.6 mm, i.d., 2.7 μm) column using 5μL injection volume with a total run time of 2 min. Acidified methanol/water mixture was used as a mobile phase. The parent/product ion transitions for metolazone (m/z 366.1/258.9) and IS (m/z 429.2/207.0) were monitored on a triple quadrupole mass spectrometer, operating in the multiple reaction monitoring and positive ion mode. The method was found to be linear in the range of 0.05 – 200 metolazone. The method was validated with respect to selectivity, linearity, accuracy, precision, recovery and stability according to accepted regulatory guidelines. The described method was successfully applied to preclinical pharmacokinetic studies of analytes after an oral administration of metolazone (1 mg/kg) in rats.
Quantification of a Novel Peptide, CPT31 in Rat and Monkey Plasma by LC-MSCovance
ASMS 2019 -- CPT31, a novel D-peptide, is being investigated in the treatment and prevention of HIV by inhibiting the viral entry of HIV. To evaluate the properties of CPT31, an accurate highly reproducible method to quantitate CPT31 in plasma was required. To this end, a robust LC-MS assay for the quantification of CPT31 in rat and monkey plasma samples is reported here. The method follows extraction and clean-up of two plasma matrices, encompasses a range of 90.0 to 45,000 ng/mL, and completes LC-MS analysis in 7.50 minutes.
VALIDATED LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY METHOD FOR DETERMINA...Manik Ghosh
A simple, highly sensitive and rapid LC-MS/MS method has been developed and validated for the quantification of metolazone in rat plasma using irbesartan as internal standard (IS). After simple protein precipitation extraction by acetonitrile, the analyte and IS were extracted from 50 μL plasma sample on an Agilent Poroshell 120, EC- C18 (50 mm × 4.6 mm, i.d., 2.7 μm) column using 5μL injection volume with a total run time of 2 min. Acidified methanol/water mixture was used as a mobile phase. The parent/product ion transitions for metolazone (m/z 366.1/258.9) and IS (m/z 429.2/207.0) were monitored on a triple quadrupole mass spectrometer, operating in the multiple reaction monitoring and positive ion mode. The method was found to be linear in the range of 0.05 – 200 metolazone. The method was validated with respect to selectivity, linearity, accuracy, precision, recovery and stability according to accepted regulatory guidelines. The described method was successfully applied to preclinical pharmacokinetic studies of analytes after an oral administration of metolazone (1 mg/kg) in rats.
This is nice presentation given by Vishal Goyani, an Analytical student of National Institute Of Pharmaceutical education and research-INDIA.
mail your query at - vngoyanii@gmail.com
Development and validation of hplc method for determination of theophylline a...IJSIT Editor
A stable, simple, rapid, precise, accurate HPLC method for analysis of Theophyllinee and 1-Methyl
Uric Acid was developed and validated as per ICH guidelines without need of any internal standard.
Separation was carried out using X’terra RP18 (250*4.6) mm, 5µ column with potassium dihydrogen
orthophosphate buffer (pH 3): acetonitrile (30:70 v/v) as mobile phase with flow rate 1 mL min-1. The
parameters studied were retention time, linearity and range, accuracy, precision. The proposed method can
be used for determination of Theophylline and 1-Methyl Uric Acid from Human plasma.
Validation of Factor IIa for heparin sodium or heparin injectionkrishgen
A chromogenic assay intended for the quantitative determination in purified solutions by measurement of factor IIa or Xa inhibition activity. The kit can be used for 100 test reactions as per microtiter plate protocol.
Plants concentrate metals by absorbing them from the soil in which they are grown. Some metals are beneficial and essential for life whereas other metals are highly toxic and have negative effects with even the lowest of levels. Because of their toxicity, quantification of these elements is needed. This application will investigate the preparation and analysis for heavy metals in Cascade Hops using Shimadzu AA-7000 with Graphite Furnace Atomic Absorption and Cold Vapor techniques.
LC-MS/MS method for the quantification of carbinoxamine in human plasmaIOSR Journals
A simple, reverse-phase high performance liquid chromatographic method with mass spectrometric detection (HPLC-MS/MS) was developed for determination of carbinoxamine in human plasma using pargeverine HCl as an internal standard. The procedure involves a simple protein precipitation technique using BDS HYPERSIL C8 (100 x 4.6mm) column. The mobile phase used was acetonitrile: buffer (25mm ammonium formate solution) (80:20). Precipitation was done using acetonitrile and detection was done in MRM mode, using an Electro Spray positive ionization. The ion transition monitored was (m/z) carbinoxamine (Q1 Mass: 291.2; Q3 Mass: 167.1), Internal standard (Q1 Mass: 338.1; Q3 Mass; 167.0). The retention time of carbinoxamine and internal Standard were 1.61 and 1.75 respectively. Method was evaluated in terms of linearity, accuracy, precision, recovery, sensitivity. The simple extraction procedure and short chromatographic runtime make the method suitable for therapeutic drug monitoring studies.
Poster demonstrating the results from the development/verification project for the quantitation of all- trans retinol and alpha tocopherol in human serum.
This is nice presentation given by Vishal Goyani, an Analytical student of National Institute Of Pharmaceutical education and research-INDIA.
mail your query at - vngoyanii@gmail.com
Development and validation of hplc method for determination of theophylline a...IJSIT Editor
A stable, simple, rapid, precise, accurate HPLC method for analysis of Theophyllinee and 1-Methyl
Uric Acid was developed and validated as per ICH guidelines without need of any internal standard.
Separation was carried out using X’terra RP18 (250*4.6) mm, 5µ column with potassium dihydrogen
orthophosphate buffer (pH 3): acetonitrile (30:70 v/v) as mobile phase with flow rate 1 mL min-1. The
parameters studied were retention time, linearity and range, accuracy, precision. The proposed method can
be used for determination of Theophylline and 1-Methyl Uric Acid from Human plasma.
Validation of Factor IIa for heparin sodium or heparin injectionkrishgen
A chromogenic assay intended for the quantitative determination in purified solutions by measurement of factor IIa or Xa inhibition activity. The kit can be used for 100 test reactions as per microtiter plate protocol.
Plants concentrate metals by absorbing them from the soil in which they are grown. Some metals are beneficial and essential for life whereas other metals are highly toxic and have negative effects with even the lowest of levels. Because of their toxicity, quantification of these elements is needed. This application will investigate the preparation and analysis for heavy metals in Cascade Hops using Shimadzu AA-7000 with Graphite Furnace Atomic Absorption and Cold Vapor techniques.
LC-MS/MS method for the quantification of carbinoxamine in human plasmaIOSR Journals
A simple, reverse-phase high performance liquid chromatographic method with mass spectrometric detection (HPLC-MS/MS) was developed for determination of carbinoxamine in human plasma using pargeverine HCl as an internal standard. The procedure involves a simple protein precipitation technique using BDS HYPERSIL C8 (100 x 4.6mm) column. The mobile phase used was acetonitrile: buffer (25mm ammonium formate solution) (80:20). Precipitation was done using acetonitrile and detection was done in MRM mode, using an Electro Spray positive ionization. The ion transition monitored was (m/z) carbinoxamine (Q1 Mass: 291.2; Q3 Mass: 167.1), Internal standard (Q1 Mass: 338.1; Q3 Mass; 167.0). The retention time of carbinoxamine and internal Standard were 1.61 and 1.75 respectively. Method was evaluated in terms of linearity, accuracy, precision, recovery, sensitivity. The simple extraction procedure and short chromatographic runtime make the method suitable for therapeutic drug monitoring studies.
Poster demonstrating the results from the development/verification project for the quantitation of all- trans retinol and alpha tocopherol in human serum.
Póster presentado en las I Jornadas Internacionales de Innovación Docente Universitaria en entornos de aprendizaje enriquecidos. Universidad Nacional de Educación a distancia. Madrid, del 19 al 21 de septiembre de 2012. Resumen en actas de Jornadas y disponible en http://congresos.uned.es/w3433/actividad_ponencias/ponencia/100
Presentación preparada con motivo de conferencia invitada en State University of San Diego (California, Estados Unidos), durante estancia académica en el marco del proyecto de investigación Audiencias Activas y Periodismo. Febrero de 2015. María Sánchez González. Más información en www.cibermarikiya.com/cronica-de-mi-estancia-academica-en-california-estados-unidos
Contoh-contoh alat musik melodis, harmonis, dan ritmis.Mengenal notasi balok, membaca not dalam paranada serta mengenal kunci musik beserta letak nada urutannya
Common Diagnostic pitfalls with coagulation disorders lies in addressing challenges in preanalytical processes & implementation of algorithms as per newer guidelines.
Venous and arterial blood gas analysis in the ED: What we know and what we don'tkellyam18
This presentation delivered at the International Conference on Emergency Medicine in Dublin summarises agreement between venous and arterial blood gas parameters and utility of venous blood gas analysis in emergency department clinical practice. It also highlights important gaps in our knowledge on this topic.
International Journal of Pharmaceutical Science Invention (IJPSI)inventionjournals
International Journal of Pharmaceutical Science Invention (IJPSI) is an international journal intended for professionals and researchers in all fields of Pahrmaceutical Science. IJPSI publishes research articles and reviews within the whole field Pharmacy and Pharmaceutical Science, new teaching methods, assessment, validation and the impact of new technologies and it will continue to provide information on the latest trends and developments in this ever-expanding subject. The publications of papers are selected through double peer reviewed to ensure originality, relevance, and readability. The articles published in our journal can be accessed online.
Similar to Thrombin Generation Assays ISTH poster 2009 (20)
International Journal of Pharmaceutical Science Invention (IJPSI)
Thrombin Generation Assays ISTH poster 2009
1. Comparison of Three different Thrombin Generation Assays in Patients with
Haemophilia
Aghighi S., Riddell A., Chowdary P., Gatt A. Katharine Dormandy Haemophilia Centre & Thrombosis Unit, Royal Free Hospital, Pond Street, London NW3 2QG,
United Kingdom
Introduction
• Several commercial thrombin generation tests (TGT) are now available.
• Recent studies have reported the application of TGT to evaluate patients with hyper
or hypo-coagulopathy 1, 2, 3
•Several studies have reported low thrombin generation in patients with severe
Haemophilia A (HA) 4, 5, 6
.
•However, due to different sample preparation techniques, phospholipid
concentrations and tissue factor concentrations employed, comparability of results
between studies is difficult, including thrombin generation assays with corn trypsin
inhibitor (CTI) 5, 6
.
Conclusion:The harmonisation of the results, as recommended by the TGT ISTH SSC
working party, improved comparability of the parameters from the three different thrombin
generation tests used in this group of Haemophilia patients
Patient Group & Control Group: .46 male patients with Haemophilia A (26
severe, 10 moderate and 10 mild) and a control group comprising of 25 healthy
volunteers.
Results: Median and inter-quartile ranges are shown for peak height (PH) (figures A, B and C)
and ttPeak (figures D, E and F). Only PH in in-house TGT was significantly different between
moderate and severe HA (P = 0.0029), and in Ceveron® alpha assay PH were significantly were
different between moderate and mild HA (P = 0.0378).
No significant difference was found between the PH of the in-house TGT and Thrombogram®
and
they correlated relatively well (r = 0.520, P = 0.0001). No significant difference was found between
PH of in-house TGT and Ceveron®
alpha and also correlated relatively well (r = 0.503, P = 0.0002).
There was a significant difference between PH of Thrombogram®
and Ceveron®
alpha (P = 0.0309)
however they correlated (r = 0.5131, P = 0.0001). The sensitivity of in-house TGT was higher (table
1 and 2) than the Thrombogram® and Ceveron® alpha.
Discussion: In general, the study showed that all assays have a good specificity for
distinguishing those patients with haemophilia from normal, however their sensitivities were
different. Our results showed that the sensitivity of PH in-house TGT assay is higher when
compared with other two assays. The results also showed that harmonisation of the results may
help the correlations of the parameters but was not strong enough therefore showing the
difference between methods. This may be as a result of different sources and/or concentrations
of tissue factor or phospholipids in the assays.
Methods & Materials: Venous whole blood was collected into tri-sodium citrate (0.106M)
and 20µg/mL corn trypsin inhibitor (CTI) (Cambridge, UK). Samples were double centrifuged at
2000g for 12 minutes. All samples were then centrifuged at 6000 rpm for 2 minutes. Samples
were aliquoted and frozen at -85°C prior to testing. A pooled normal plasma containing 20µg/mL
CTI was prepared (as above) from 10 healthy volunteers.
In-House TGT: Samples were diluted 2:3 with in-house trigger reagent (tissue factor (Innovin,
Sysmex, Milton Keynes, UK) diluted 1:6000 to achieve final concentration ~1pM, 4µM
phospholipids (60%PC,20%PE, 20%PS) Avanti Polar Lipids (Delfzyl, The Netherland) , 0.1M
CaCl2 and 0.41mM z-Gly-Gly-Arg-AMC.HCL flurogenic substrate (Bachem, Switzerland).
Parameters used were area under curve (AUC) in relative fluroescent units (RFU), Peak Height
(PH), time to Peak Height (ttPeak).
Calibrated Automated Thrombogram (CAT) (Thrombinoscope BV, Netherlands): Samples
were diluted 2:3 with PPP low reagent (tissue factor final concentration 1pM- final concentrations ,
4µM phospholipids, 0.1M CaCl2 and 0.41mM z-Gly-Gly-Arg-AMC.HCL flurogenic substrate. All
samples were compared to a calibrator well and the parameters analysed were ETP (nM.min)
Peak (nM), time to Peak Height (ttPeak).
Technothrombin TGA RCL Assay on the Ceveron® Alpha (Technoclone, Vienna, Austria):
Samples were diluted 2:7 in RCL reagent to make a final concentration of 0.5pM tissue factor
and 0.34 mM CaCl2, low phospholipid concentration and 0.5mM ZGGR-AMC flurochrom.
Parameters analysed were AUC RCL (nM.min), Peak-RCL (nM).
To harmonise the parameters results were normalised by calculating percentage of test
plasma/normal pooled plasma control used in all three TGTs
References: 1. Besser M, Baglin C, Luddington R,et al. (2007) High rate of unprovoked recurrent venous thrombosis is associated with high thrombin generation potential in a procpective cohort study. J Thormb Haemost Oct 6 (10). 2. LuddingtonR, Grigorov R, Wiens L. et al (2009). First experiences with the measurement of Thrombin Generation(TGA) on the Ceveron®alpha in the routine lab.GTH
poster presentation. 3. Matsumoto, T., & Ogiwara, K. (2008). New assays for monitoring haemophilia treatment. Haemophilia, 14 Suppl 3, 83. 4. Beltran-Miranda C, Khan A, Jaloma-Cruz, A, Laffan, M. (2005) Thrombin generation and phenotypic correlation in haemophilia A. Haemophilia 11(4). 5. Lewis S, Stephens E, Florou G et al. (2007). Measurement of global haemostasis in severe haemophilia A
following factor VIII infusion. Br J Haemtol 183 (6) 6. van Veen J, Gatt A, Cooper P, et al. (2008) Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters . Blood. Coag Fibrinolysis 19 (3) 183.
Aim: To evaluate three TGT assays in a group of patients with Haemophilia A using
a in-house normal pooled plasma to harmonise the results.
Peak Height
Ceveron® alpha
Severe Moderate Mild
0
20
40
60
80
100
%
ttPeak
Thrombogram®
Severe Moderate Mild
0
10
20
30
Min
Peak Height
In-house TGT
Severe Moderate Mild
0
20
40
60
80
%
ttPeak
In-house TGT
Severe Moderate Mild
0
20
40
60
Min
All HA
Peak Height Time to Peak
Sensitivity
%
Specificity
%
Likelihood
ratio
Sensitivity
%
Specificity
%
Likelihood
ratio
In-house TGT 99.0 94.4 17.8 86.6 94.4 15.6
Thrombogram® 92.7 95.0 9.3 77.0 95.0 15.4
Ceveron®
alpha 92.6 94.7 17.6 87.0 94.7 16.5
Mild HA
Peak Height Time to Peak
Sensitivity
%
Specificity
%
Likelihood
ratio
Sensitivity
%
Specificity
%
Likelihood
ratio
In-house TGT 93.8 94.4 16.9 75.0 94.4 13.5
Thrombogram® 92.3 90.0 9.2 61.5 95.0 12.3
Ceveron®
alpha 78.6 94.7 14.9 78.6 94.7 14.9
Peak height
Thrombogram®
Severe Moderate Mild
0
20
40
60
%
A B
C
D
E
F
Ceveron® alpha
Severe Moderate Mild
0
10
20
30
40
ttPeak
%
Table 1. ROC analysis of all haemophilia A patients (n = 46) Table 2. ROC analysis of mild haemophilia A patients (n = 10)
Acknowledgement: Technoclone Ltd Surry, UK